Concepedia

Zivia Brunschwig

ZB

3

Publications

386

Citations

3

H-Index

2011

Active since

Affiliations

Hebrew University of Jerusalem(Current)

Hadassah Medical Center

Tel Aviv University

Sheba Medical Center

Zivia Brunschwig is an author at Hebrew University of Jerusalem specializing in cell biology, medicine, and oxidative stress.

Top concepts

Publications per year

2011–2013

3

Publications

3

Mutant KRAS is a druggable target for pancreatic cancer

Elina Zorde Khvalevsky, Racheli Gabai, Itzhak H. Rachmut et al. · Proceedings of the National Academy of Sciences · 2013 · 286 citations · Full text

, , +11

Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the <i>dy<sup>2J</sup>/dy<sup>2J</sup></i> Mouse

Nurit Yanay, Shlomit Aga‐Mizrachi, Zivia Brunschwig et al. · Annals of Neurology · 2011 · 79 citations

The Ras Antagonist, Farnesylthiosalicylic Acid (FTS), Decreases Fibrosis and Improves Muscle Strength in dy2J/dy2J Mouse Model of Muscular Dystrophy

Yoram Nevo, Shlomit Aga‐Mizrachi, Edva Elmakayes et al. · PLoS ONE · 2011 · 21 citations · Full text

, , +23

Rows per page

1–3 of 3